FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883208512> ?p ?o ?g. }

• W2883208512 endingPage "114" @default.
• W2883208512 startingPage "104" @default.
• W2883208512 abstract "Introduzione. Prevenire le occlusioni dei dispositivi di accesso venoso centrale (DAVC) è cruciale per la continuití e qualití delle cure. Vi è ampio consenso sulla necessití di eseguire un periodico lavaggio del lume del presidio per assicurarne la pervietí . Le soluzioni più utilizzate sono la soluzione con eparina (SE) e la soluzione fisiologica (NaCl 0.9% - SF). Sussistono ancora pareri controversi sullefficacia della SE rispetto alla SF. Obiettivo. Valutare lefficacia della SE rispetto alla SF per prevenire le occlusioni nei DAVC.Metodi. E stata implementata il 4 aprile 2017 una strategia di ricerca su quattro database elettronici (The Cochrane Library, Medline, Embase, CINAHL). I record restituiti sono stati analizzati in modo indipendente; quelli rispettanti i criteri di inclusione sono stati reperiti in full text. Sono state incluse revisioni sistematiche di RCT o studi quasi sperimentali che hanno confrontato lutilizzo della SE con la SF. La valutazione di qualití delle revisioni è avvenuta con la AMSTAR checklist.Risultati. Sette revisioni sistematiche di qualití moderata-alta hanno rispettato i criteri di inclusione. La SE non è stata superiore alla SF nel prevenire le occlusioni dei DAVC.Discussione. Le revisioni incluse sono state di alta qualití metodologica; leterogeneití statistica fra RCT è stata bassa mentre leterogeneití clinica e metodologica è stata elevata. Conclusioni. La SE non è stata più efficace della SF per prevenire le occlusioni dei DAVC. In attesa di studi di qualití migliore indirizzati alla valutazione della procedura di gestione complessiva dei DAVC, sembra ragionevole consigliare lutilizzo della SF.Parole chiave. sinossi, efficacia, eparina non frazionata, soluzione fisiologica, dispositivo di accesso venoso centrale, occlusione ________Synopses of systematic reviews on effectiveness of heparin to prevent occlusion in central venous access devicesABSTRACTIntroduction. Prevention of central venous access devices (CVAD) occlusion is crucial to the continuity and quality of care. There is wide consensus on the need to carry out a periodic flushing of the lumen of device in order to ensure its patency. The most commonly used solutions are the heparin solution (HS) and the physiological solution (NaCl 0.9% - PS). There are still controversial opinions on HSs effectiveness over PS. Objective. To evaluate the effectiveness of HS compared to PS to prevent occlusion in CVAD.Methods. A search strategy on four electronic databases (The Cochrane Library, Medline, Embase, CINAHL) was implemented on April 4, 2017. Records returned were independently analyzed; those complying with inclusion criteria were found in full text. Theyve been included systematic reviews of RCT or quasi-experimental studies that have compared the use of HS with PS. The quality assessment of reviews was done with AMSTAR checklist.Results. Seven moderate-high quality systematic reviews met inclusion criteria. HS is was not superior to PS in preventing CVAD occlusions.Discussion. Reviews included were of high quality methodological. The statistical heterogeneity between RCT was low while the clinical and methodological heterogeneity was high. Conclusions. HS was no longer effective than PS to prevent CVAD occlusions. Waiting for better quality studies to evaluate the overall DAVC management process, it seems reasonable to recommend using PS.Keyword. Synopsis, effectiveness, non-fractionef heparin, physiological solution, central venous access device, occlusion" @default.
• W2883208512 created "2018-08-03" @default.
• W2883208512 creator A5034724373 @default.
• W2883208512 creator A5056201208 @default.
• W2883208512 creator A5085800163 @default.
• W2883208512 date "2018-01-01" @default.
• W2883208512 modified "2023-09-27" @default.
• W2883208512 title "Synopses of systematic reviews on effectiveness of heparin to prevent occlusion in central venous access devices" @default.
• W2883208512 cites W1520952444 @default.
• W2883208512 cites W1527466436 @default.
• W2883208512 cites W1533038260 @default.
• W2883208512 cites W1547290897 @default.
• W2883208512 cites W1877658191 @default.
• W2883208512 cites W1923049078 @default.
• W2883208512 cites W1931146984 @default.
• W2883208512 cites W1965437263 @default.
• W2883208512 cites W1969101733 @default.
• W2883208512 cites W1985667424 @default.
• W2883208512 cites W1991448387 @default.
• W2883208512 cites W2007872832 @default.
• W2883208512 cites W2033058059 @default.
• W2883208512 cites W2035046761 @default.
• W2883208512 cites W2037552682 @default.
• W2883208512 cites W2050477557 @default.
• W2883208512 cites W2051106992 @default.
• W2883208512 cites W2061991526 @default.
• W2883208512 cites W2103474881 @default.
• W2883208512 cites W2112366983 @default.
• W2883208512 cites W2119790985 @default.
• W2883208512 cites W2126672009 @default.
• W2883208512 cites W2130467619 @default.
• W2883208512 cites W2131428092 @default.
• W2883208512 cites W2131972531 @default.
• W2883208512 cites W2136123911 @default.
• W2883208512 cites W2147709868 @default.
• W2883208512 cites W2157033333 @default.
• W2883208512 cites W2162434022 @default.
• W2883208512 cites W2192093071 @default.
• W2883208512 cites W2488310823 @default.
• W2883208512 cites W2569258052 @default.
• W2883208512 doi "https://doi.org/10.7429/pi.2018.712104" @default.
• W2883208512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30029298" @default.
• W2883208512 hasPublicationYear "2018" @default.
• W2883208512 type Work @default.
• W2883208512 sameAs 2883208512 @default.
• W2883208512 citedByCount "0" @default.
• W2883208512 crossrefType "journal-article" @default.
• W2883208512 hasAuthorship W2883208512A5034724373 @default.
• W2883208512 hasAuthorship W2883208512A5056201208 @default.
• W2883208512 hasAuthorship W2883208512A5085800163 @default.
• W2883208512 hasBestOaLocation W28832085121 @default.
• W2883208512 hasConcept C142362112 @default.
• W2883208512 hasConcept C15708023 @default.
• W2883208512 hasConcept C17744445 @default.
• W2883208512 hasConceptScore W2883208512C142362112 @default.
• W2883208512 hasConceptScore W2883208512C15708023 @default.
• W2883208512 hasConceptScore W2883208512C17744445 @default.
• W2883208512 hasIssue "71" @default.
• W2883208512 hasLocation W28832085121 @default.
• W2883208512 hasLocation W28832085122 @default.
• W2883208512 hasOpenAccess W2883208512 @default.
• W2883208512 hasPrimaryLocation W28832085121 @default.
• W2883208512 hasRelatedWork W135163757 @default.
• W2883208512 hasRelatedWork W1557907936 @default.
• W2883208512 hasRelatedWork W2111865594 @default.
• W2883208512 hasRelatedWork W2123836397 @default.
• W2883208512 hasRelatedWork W2248387313 @default.
• W2883208512 hasRelatedWork W2748952813 @default.
• W2883208512 hasRelatedWork W2899084033 @default.
• W2883208512 hasRelatedWork W3006587989 @default.
• W2883208512 hasRelatedWork W3203105381 @default.
• W2883208512 hasRelatedWork W1832118649 @default.
• W2883208512 isParatext "false" @default.
• W2883208512 isRetracted "false" @default.
• W2883208512 magId "2883208512" @default.
• W2883208512 workType "article" @default.